Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
Luis Jaime Castro‐Vega(Centre National de la Recherche Scientifique), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Pierre Rustin(Inserm), Olivier Chabre(Hôpital Albert Michallon), Marine Guillaud-Bataille, Emmanuel Khalifa(Délégation Paris 5), Aguirre A. de Cubas(Medical University of South Carolina), Patrick J. Pollard(University of Oxford), V. Franco‐Vidal(RELX Group (Netherlands)), Judith Favier(Inserm), Mélanie Menara(Délégation Paris 5), Sharona Azriel(Hospital Universitario Infanta Sofía), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Álvaro Gómez-Graña(Spanish National Cancer Research Centre), Aurélie Morin(Centre National de la Recherche Scientifique), Laurence Amar(Unit of Functional and Adaptive Biology), Isabelle Bourdeau(Centre Hospitalier de l’Université de Montréal), Alexandre Buffet(Inserm), Alberto Cascón(Spanish National Cancer Research Centre), Rocío Letón, Christophe Simian(Assistance Publique – Hôpitaux de Paris), María Currás-Freixes(Spanish National Cancer Research Centre)
Cited by 394
Related Papers
The ratio of the nucleon structure functions F2N for iron and deuterium
|Physics Letters B|1983|1.1k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772